AI analysis of one-year CT changes predicts disease progression and survival in fibrotic interstitial lung disease.
Key Details
- 1Researchers at National Jewish Health used an AI-based tool to detect subtle increases in lung fibrosis on serial CT scans.
- 2A 5% or more increase in fibrosis score over one year doubled the risk of death or lung transplant for patients.
- 3AI-derived fibrosis changes predicted steeper lung function decline, especially in patients with less severe baseline disease.
- 4The deep learning method, data-driven textural analysis (DTA), provided precise, objective fibrosis quantification.
- 5Results were validated with data from the Pulmonary Fibrosis Foundation Patient Registry, demonstrating generalizability.
- 6Quantitative CT analysis could be used for trial endpoints and real-world risk stratification.
Why It Matters
This study demonstrates the clinical potential of deep learning-based CT quantification for early risk identification and outcome prediction in fibrotic lung disease. It supports wider use of imaging AI as an objective, reproducible tool for prognosis and treatment decision-making in complex pulmonary disorders.
Source
EurekAlert
Related News
•EurekAlert
FDA Approves Johns Hopkins AI Tool for Early Sepsis Detection
FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
•EurekAlert
AI-Driven Handheld Endomicroscope Enhances Early Cancer Detection
Researchers develop PrecisionView, a handheld AI-powered endomicroscope for real-time, high-resolution cancer diagnostics.
•EurekAlert
AI Model Uses EKG and EHR Data to Predict Sudden Cardiac Arrest
Researchers have developed AI models that analyze EKG and EHR data to predict risk of sudden cardiac arrest in the general population.